Editors of Advanced Drug Delivery Reviews
@ADDReditors
Followers
3K
Following
140
Media
668
Statuses
2K
Via this account, the editors of Advanced Drug Delivery Reviews share new publications. Likes/retweets/follows do not endorse any particular viewpoint.
Joined May 2019
ADDR 50 days' free access: DNA-based nanostructures for cell membrane receptor regulation and disease treatment. By Zhenbao Liu & coworkers @CentralSouth_U.#DNAnanostructure #ReceptorRegulation.
0
0
0
ADDR Open Access: Classic versus innovative strategies for immuno-therapy in pancreatic cancer. By Giuseppe Lamberti & coworkers @Unibo.#CellTherapy #microbiota #PancreaticCancer.
0
1
1
ADDR Open Access: Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenvironment Challenges. By Ronit Satchi-Fainaro & coworkers @RSFLab @TAUMedFaculty.#3Dprinting #PersonalizedTherapy.
0
2
3
ADDR Open Access: Towards Airway Microbiome Engineering for Improving Respiratory Health. By Kelsey E. Hern & Arthur Prindle @NUFeinbergMed.#MicrobiomeEngineering #probiotics #SyntheticBiology .
0
0
0
ADDR 50 days' free access: Predicting population dynamics of antimicrobial resistance using mechanistic modeling and machine learning. By Lingchong You & coworkers @DukeUBME.#MachineLearning #modeling #antimicrobial .
0
0
0
ADDR 50 days' free access: Applications of DNA-based nanostructures in immunotherapy. By Baoquan Ding & coworkers @Nanocenter_.#DNAnanostructure #immunotherapy.
0
0
0
ADDR 50 days' free access: Advances in Carbon Nanomaterials and their Polymeric Composites in Neural Tissue Engineering. By Iman Noshadi & coworkers @UCRBioengineeri.#CarbonNanomaterial #TissueEngineering.
0
1
2
ADDR 50 days' free access: The molecular circadian clock: From fundamental mechanisms to therapeutic promise in neurological disorders. By Aarti Jagannath & coworkers @aartijagannath @NDCNOxford.#CircadianRhythm #NeurologicDisorder.
0
1
2
ADDR Open Access: Convection-enhanced delivery for brain malignancies: technical parameters, formulation strategies and clinical perspectives. By Karolina Dziemidowicz & coworkers @School_Pharmacy @UKICRS .#BrainDelivery #convection #formulation .
0
0
0
ADDR Open Access: Carbon Dots as multi-modal contrast agents: opportunities and open challenges for in vivo bioimaging. By Maurizio Prato & coworkers @brta_eus @CRS_SPLC .#bioimaging #CarbonDot #ContrastAgent.
0
0
0
ADDR 50 days' free access: Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disorders. By Nektarios Tavernarakis & coworkers, Institute of Molecular Biology and Biotechnology.
0
1
1
ADDR 50 days' free access: 3D printing-enabled spatial patterning of biomimetic signals for bone tissue engineering. By Antonios G. Mikos & coworkers @Rice_BIOE.#3Dprinting #bioink #TissueEngineering .
0
3
3
ADDR 50 days' free access: Gut-Brain-Immune Interactions: Exploring Probiotics as a Drug Delivery Platform for Neurological Disease. By Thomas J. Mansell & coworkers @ISU_CBE.#probiotics #biotherapeutics #NeurologicDisease.
0
1
1
ADDR Open Access: Harnessing Carbon Nanomaterials for Reactive Oxygen Species Regulation: Insights into Generation, Scavenging, and Sensing. By Nasim Annabi & coworkers @UclaCBE.#CarbonNanomaterial #ReactiveOxygenSpecies.
0
0
0
ADDR Open Access: Overcoming Therapy Resistance in Pancreatic Cancer: Challenges and Emerging Strategies. By Sumit Sahni & coworkers @syd_health @AustralianCRS .#PancreaticCancer #GeneEditing #mRNA.
0
0
1
ADDR 50 days' free access: Lights Out for Superbugs: Is Antimicrobial Blue Light a Potential Approach for Future Infection Control?.By Tianhong Dai & coworkers @harvardmed.#phototherapy #antimicrobial .
0
0
2
ADDR Open Access: Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers. By Zahra Rattray & coworkers @UniStrathclyde @UKICRS .#AntibodyDrugConjugate #MultimodalTherapy.
0
0
2
ADDR 50 days' free access: Navigating the complexities of pancreatic ductal adenocarcinoma: a review on therapeutic models and RAS inhibitors. By Carmen Guerra & coworkers @CNIOStopCancer @CRS_SPLC .#organoid #MouseModel .
0
2
1
ADDR 50 days' free access:Gelatin-integrated carbon nanomaterials in nanomedicine: From biosensing and bioprinting to tissue engineering and other biomedical applications. By Ali Maleki & coworkers @iust_iran.#CarbonNanomaterial #bioprinting #biosensing .
0
1
3
ADDR Open Access: From Cell-SELEX to Tissue-SELEX for Targeted Drug Delivery and Aptamer Nanomedicine. By Juewen Liu & coworkers @WINano.#aptamer #SELEX #nanomedicine .
0
1
0